Breaking News
February 24, 2019 - Study reveals insights into how the brain learns new locomotor patterns
February 24, 2019 - Depression Screening: MedlinePlus Lab Test Information
February 24, 2019 - Researchers discover a weakness in a rare cancer that could be exploited with drugs
February 23, 2019 - U.S.-based patient advocacy organizations received majority of pharma donations, finds study
February 23, 2019 - UCL and AIIMS collaborates to increase academic and student exchange
February 23, 2019 - Mechanism behind how diabetes causes muscle loss revealed
February 23, 2019 - Hepatocellular carcinoma diagnosis, prognosis and treatment may improve by identifying a protein
February 23, 2019 - The American Heart Association issues new reference toolkit for healthcare providers
February 23, 2019 - Studies explore physiological dangers that climate change will have on animal life
February 23, 2019 - Penn study reveals increase in health-related internet searches before ER visits
February 23, 2019 - Intensive therapy during early stages of MS leads to better long-term outcomes
February 23, 2019 - Prenatal Fluconazole Exposure Increases Neonatal Risks
February 23, 2019 - Mental Health Screening: MedlinePlus Lab Test Information
February 23, 2019 - Study suggests birth mechanics are part of the process that leads to autism
February 23, 2019 - Unhealthy diet linked to poor mental health
February 23, 2019 - Study gives a snapshot of crocodile evolution
February 23, 2019 - Research finds steep rise in self-poisonings among young people
February 23, 2019 - American Gastroenterological Association announces “AGA Future Leaders Program”
February 23, 2019 - Scientists uncover new mechanisms regulating neural stem cells
February 23, 2019 - Combinations of certain insecticides turn out to be lethal for honeybees
February 23, 2019 - AHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?
February 23, 2019 - NIMH » Anxiety Disorders
February 23, 2019 - Autistic people urgently need access to tailored mental health support
February 23, 2019 - Newly designed molecule could benefit people with Friedrich’s Ataxia
February 23, 2019 - Chinese CRISPR twins may have better cognition and memory
February 23, 2019 - Study finds new genetic clues associated with asthma in African ancestry populations
February 23, 2019 - Fetal signaling pathways may offer future opportunities to treat lung damage
February 23, 2019 - Early-stage osteoarthritis drug wins prestigious innovation award
February 23, 2019 - Researchers report positive findings with dasotraline for ADHD in children ages 6-12
February 23, 2019 - News study reanalyzes the effects of noncaloric sweeteners on gut microbiota
February 23, 2019 - New device allows scientists to reproduce blow effects on the heart in lab
February 23, 2019 - Holy herb identified as a potential treatment for Alzheimer’s disease
February 23, 2019 - New technology platform digitally counts growth factors in single cells
February 23, 2019 - Physicians still remain at higher risk for burnout compared to other professionals
February 23, 2019 - Surgery and other treatments offer viable options for adult scoliosis
February 23, 2019 - Reduced antibody adaptability may make the elderly more vulnerable to influenza
February 23, 2019 - Researchers find increased rates of CRC screening in Kentucky after Medicaid expansion
February 23, 2019 - Neighborhood income, education associated with risk of disability progression in MS patients
February 23, 2019 - Endocrine Society opposes new rule that restricts access to Title X Family Planning Program
February 23, 2019 - 2019 guidelines for management of patients with atrial fibrillation
February 23, 2019 - Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation
February 23, 2019 - A just-right fix for a tiny heart
February 23, 2019 - UMass Amherst scientist explores role of citrus peel in decreasing gut inflammation
February 23, 2019 - Owlstone Medical and Shanghai Renji Hospital collaborate to initiate breath biopsy lung cancer trial
February 23, 2019 - AMSBIO’s comprehensive portfolio of knock-out cell lines and lysates
February 23, 2019 - New app reliably determines physicians’ skills in forming accurate, efficient diagnoses
February 23, 2019 - Peripheral nerve injury can trigger the onset and spread of ALS, shows study
February 23, 2019 - Researchers uncover mechanisms that prevent tooth replacement in mice
February 23, 2019 - Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
Using Pre-Clinical Imaging to Detect Cancer

Using Pre-Clinical Imaging to Detect Cancer

image_pdfDownload PDFimage_print

Please can you tell us a bit about Photon’s etc preclinical infrared imagers? What sets them apart from others on the market?

Photon Etc.’s (IR VIVO™) system is the first and only turnkey hyperspectral preclinical imager optimized for imaging in the second biological window of the infrared (NIR-II) / short-wavelength infrared (SWIR) range available on the market to our knowledge.

Our product portfolio includes different components of this preclinical imager, such as a hyperspectral filter (Hypercube™), widefield infrared imagers (S-EOS & GRAND-EOS) and cameras (ZephIR™ 1.7). This gives us a high level of control on the preclinical system, which may be customized to fit customer requirements.

Our standard IR VIVO™ preclinical system offers laser or LED illumination at wavelengths such as 730 nm or 808 nm, which are popular wavelengths for excitation of NIR-II markers such as carbon nanotubes. For detection, we can offer multispectral imaging using a filter wheel and hyperspectral imaging with a continuously tunable spectral range from 850 nm to 1620 nm and a spectral resolution of < 4 nm.

The system is also equipped with a heating plate, gas anesthesia inlet and outlet ports for up to 3 mice. Optional extensions include detection in the visible, which means that one could perform routine experiments carried out by standard preclinical optical imagers in addition to having the capability of doing hyperspectral and NIR-II imaging.

How does imaging in the second biological window differ from other optical imaging wavelengths?

There is reduced scattering as well as minimal absorption and auto-fluorescence by tissue when imaging in the second biological window (1000 to 1700 nm). As a result, there is a much better image contrast, sensitivity and penetration depth into tissue at these wavelengths than traditional visible or infrared optical imaging (i.e. 400-1000 nm).  

Reaching a penetration depth of up to 3 centimeters has a huge impact when imaging small animal like mice, since it allows the visualization of full organs as well as cellular processes in real time with a high spatial resolution.

This positions NIR-II advantageously compared with other small animal imaging modalities. Indeed, MRI, PET and CT imaging can take up minutes to hours to complete a scan, are complex, costly and ionizing in the case of PET and CT.

Furthermore, they cannot provide the micron-scale resolution of NIR-II imaging. Finally, although the increased penetration depth in the second biological window does not allow imaging through the whole human body like MRI, PET or CT, its penetration depth is ideal for applications such as small animal imaging, surgical guidance or tumor resection.

What is available in terms of technology at these wavelengths?

There are many infrared detectors available on the market. For imaging in the second biological window, indium gallium arsenide (InGaAs) based cameras offer the highest sensitivity. Originally restricted to the aerospace and military domain, InGaAs cameras are becoming more and more available to researchers.

Photon Etc. packages its own highly sensitive ZephIR™ 1.7 InGaAs camera operating at -80°C thanks to the integration of a  four-stage TE cooler. This low operating temperature allows signal detection at extremely low noise levels.

As short-wave infrared (SWIR) cameras became more accessible, researchers began testing the potential of working at these wavelengths for life science imaging. They found that a better penetration depth and image clarity could be achieved with this technology, and started developing biomedical markers that could be used at corresponding wavelengths. These fluorescent markers are essential to allow targeting biological entities.

A few NIR-II markers are already commercially available. Although it has been traditionally used for imaging around 800 nm, clinical dye indocyanine green (ICG) turns out to also have a good emission around 1300 nm. There is a clear need for more clinically approved, bright and targetable markers or dyes that emit in the second biological window.

Promising markers which are currently being developed include small molecules, quantum dots, single-walled carbon nanotubes (SWCNT) and rare earth nanoparticles. This growing number of NIR-II markers still falls short compared to the large variety of existing markers for visible imaging.

Photon Etc. works hand in hand with researchers who develop these markers to provide them with imaging tools required for their development.

We offer one of the few microscopes optimized for infrared imaging available thus far on the market, the IMA™. Our microscopes offer the option to do infrared hyperspectral imaging, which allow rapid characterization of the emission wavelength of multiple markers.

Our preclinical NIR-II imager, IR VIVO™, was also developed to fulfill the demand of researchers working in the second biological window.

Caption: Photon etc.’s ZephIR 1.7, SWIR camera

Can you tell us about some of the sample applications of NIR-II Imaging?

NIR-II imaging is ideal for the rapid visualization of deep, small anatomical features with a high degree of clarity. Sample applications include blood flow, lymphatic or metabolic imaging. Tumor detection or cell environment assessment (lipid or microRNA content, pH, temperature, etc.) are other examples which will be discussed shortly.

Diseases related to blood flow such as peripheral arterial disease affect millions of people in America. Mouse models of ischemia are used to develop therapies to improve blood flow recovery. Studies have shown that NIR-II imaging can be used to monitor quantitatively microvascularization-related processes such as tissue perfusion, heart rate or blood flow in small animals.

Indeed, NIR-II allows both visualization of small microvessels at a spatial resolution higher than μCT imaging, and blood flow quantification at a speed matching ultrasound. These capabilities are also relevant for functional imaging of activity states such as muscle motion or brain response to stimuli, which are closely linked to perfusion.

A wide range of NIR-II markers or sensors are being developed to take advantage of the high penetration depth at these wavelengths. Examples include carbon nanotube sensors that allow detection of lipid or microRNA content. Depending on the cellular environment, the emission wavelength of the carbon nanotubes will be shifted and thus allow mapping of the fat content in real time.

It has been shown that changes in a mouse diet reflects lipid content changes. It is expected for this to provide a better insight in the detection and treatment of fat liver disease. In the same way, microRNA content can be assessed through wavelength shifts. In many cases, specific microRNA expression patterns are good disease indicators.  

Source: Galassi, T. V., Jena, P. V., Shah, J., Ao, G., Molitor, E., Bram, Y., … Heller, D. A. (2018). An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo. Science Translational Medicine, 10(461), 1–10.

Can the NIR-II imager identify cancer? What impact will this have?

NIR-II imaging can allow cancer detection thanks to intrinsic tissue properties or by using targeted markers. The increased penetration depth and contrast compared with visible imaging could allow superior tumor margin delineation or assessment of tumor volume.

In terms of tumor imaging metrics, it has been shown that using NIR-II markers can yield a significant improvement in tumor-to-normal (T/NT) ratio thanks to reduced background autofluorescence and scattering of tissue at these wavelengths. This means improved ability to detect tumors at earlier stages.

For research purposes, the detection of tumors at earlier stages and the monitoring of their progression may enable a better understanding of tumorigenesis and facilitate the assessment of treatment efficacy. NIR-II also enables monitoring the vascular activity, which is closely related to tumor growth through angiogenesis.

Clinically, NIR-II imaging has the potential to become a highly sensitive, rapid and inexpensive tool for intraoperative image-guided tumor resection. With the appropriate markers developed to target cancer, NIR-II imaging could reduce the incidence of positive surgical margins and therefore the risk of cancer recurrence.

Source: Williams, R. M., Lee, C., Galassi, T. V, Harvey, J. D., Leicher, R., Sirenko, M., … Heller, D. A. (2018). Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. Science Advances, 4(4).

What does NIR-II imaging mean for the future of preclinical imaging?

NIR-II imaging will bring an unprecedented combination of fast, high resolution and penetration depth imaging at lower cost and to a broader community than current preclinical imaging techniques.

This will enable to resolve and track single biomedical targets or processes throughout small animals, thereby opening a new window of possibilities for fundamental and biopharmaceutical research.

Where can our readers go to find out more?

Please see our website page for IR VIVO™ system and IMA™.  

Jena, P. V., Roxbury, D., Galassi, T. V., Akkari, L., Horoszko, C. P., Iaea, D. B., … Heller, D. A. (2017). A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux. ACS Nano, 11(11), 10689–10703.

Williams, R. M., Lee, C., Galassi, T. V, Harvey, J. D., Leicher, R., Sirenko, M., … Heller, D. A. (2018). Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. Science Advances, 4(4).

About Émilie Beaulieu Ouellet

A biomedical engineer by training, Émilie Beaulieu Ouellet is Application Scientist for life science imaging at Photon Etc. During her graduate studies at Polytechnique Montreal, she specialized in biophotonics, more specifically in the design of microscopes and endoscopes.

Émilie then worked as a biosystems field support specialist and technical representative for microscopy systems at Nikon Instruments. She later joined the Tearney group at Harvard Medical School as an optical engineer for the design and manufacturing of endoscopes for gastrointestinal imaging.

With 10 years experience in biophotonics, plus extensive exposure to varied applications in life science, Émilie strives to bring the latest innovations in biophotonics to the life science market.


(i) Dion-Bertrand, L.-I. (2016). Hyperspectral Microscopy: A Powerful Technique for Multiplexed Imaging. Biophotonics, 23(8), 20–22.

Antaris, A. L., Chen, H., Cheng, K., Sun, Y., Hong, G., Qu, C., … Dai, H. (2016). A small-molecule dye for NIR-II imaging. Nature Materials, 15(2), 235–242.

Ding, F., Zhan, Y., Lu, X., & Sun, Y. (2018). Recent advances in near-infrared II fluorophores for multifunctional biomedical imaging. Chemical Science, 9(19), 4370–4380.

Bardhan, N. M., Dang, X., Qi, J., & Belcher, A. M. (2018). US 2018/0042483 A1. United States.

Dion-Bertrand, L.-I. (2016). Hyperspectral Microscopy: A Powerful Technique for Multiplexed Imaging. Biophotonics, 23(8), 20–22.

Lessard, Simon & Dion-Bertrand, Laura-Isabelle. (2017). COOLING SWIR SENSORS – AN OVERVIEW. 10.13140/RG.2.2.31365.65764.

Jena, P. V., Roxbury, D., Galassi, T. V., Akkari, L., Horoszko, C. P., Iaea, D. B., … Heller, D. A. (2017). A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux. ACS Nano, 11(11), 10689–10703.

Bruns, O. T., Bischof, T. S., Harris, D. K., Franke, D., Shi, Y., Riedemann, L., … Bawendi, M. G. (2017). Next-generation in vivo optical imaging with short-wave infrared quantum dots. Nature Biomedical Engineering, 1(4).

Hong, G., Lee, J. C., Jha, A., Diao, S., Nakayama, K. H., Hou, L., … Huang, N. F. (2014). Near-Infrared II Fluorescence for Imaging Hindlimb Vessel Regeneration with Dynamic Tissue Perfusion Measurement Guosong. Circ Cardiovasc Imaging, 7(3), 517–525.

Franke, D., Harris, D. K., Chen, O., Bruns, O. T., Carr, J. A., Wilson, M. W. B., & Bawendi, M. G. (2016). Continuous injection synthesis of indium arsenide quantum dots emissive in the short-wavelength infrared. Nature Communications, 7, 1–9.

Ghosh, D., Bagley, A. F., Na, Y. J., Birrer, M. J., Bhatia, S. N., & Belcher, A. M. (2014). Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes. Proceedings of the National Academy of Sciences, 111(38), 13948–13953.

Antaris, A. L., Chen, H., Cheng, K., Sun, Y., Hong, G., Qu, C., … Dai, H. (2016). A small-molecule dye for NIR-II imaging. Nature Materials, 15(2), 235–242.

Galassi, T. V., Jena, P. V., Shah, J., Ao, G., Molitor, E., Bram, Y., … Heller, D. A. (2018). An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo. Science Translational Medicine, 10(461), 1–10.  

Tagged with:

About author

Related Articles